Michael Bigham, Executive Chairman of the Board at Paratek Pharmaceuticals, Inc. (PRTK), sold 31,250 shares at $2.20 ($69K) on 2023-08-09, disclosed to the SEC on 2023-08-10.
Scheduled sale ($69k) by Executive Chairman of the Board under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PRTK | SELL | 2022-11-01 | $21K | — | Filing → |
| PRTK | SELL | 2022-08-10 | $152K | — | Filing → |
| PRTK | SELL | 2021-12-15 | $212K | — | Filing → |